Leadership

Susan Stewart, JD, LLM

Chief Regulatory Officer

Susan Stewart, JD, is Frequency Therapeutics’ Chief Regulatory Officer. With 30 years of experience in biopharmaceutical regulatory affairs, Ms. Stewart oversees and develops innovative regulatory strategies, leading interactions with global health authorities. In addition to being an independent regulatory consultant for several years, she also serves as Chief Regulatory Officer at Kaleido Biosciences, where she was previously Senior Vice President of Regulatory and Quality, and as Chief Regulatory Officer for Candel Therapeutics.  She served as Senior Vice President of Regulatory Affairs, Quality and Compliance at Tokai Pharmaceuticals and Vice President, Regulatory Affairs at Transmolecular. She also spent 13 years at Genzyme Corporation in regulatory and compliance roles, including serving as Vice President, Regulatory Affairs, after beginning her career with Abbott Laboratories in Regulatory and Quality positions. She received her J.D. from Concord Law School at Purdue University Global, her LL.M from the Maurice A. Deane School of Law, Hofstra University and her B.A. from the University of Massachusetts.